🇺🇸 FDA
Patent

US 7288369

Replication competent hepatitis C virus and methods of use

granted A61KA61K48/00

Quick answer

US patent 7288369 (Replication competent hepatitis C virus and methods of use) held by The Board of Regents of the University of Texas System expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K48/00